MeSH term
Frequency | Condition_Probility | Animals | 91 | 0.0 |
Humans | 378 | 0.0 |
Adult | 185 | 0.0 |
Aged | 47 | 0.0 |
*Evoked Potentials | 2 | 20.0 |
Female | 205 | 0.0 |
Male | 214 | 0.0 |
Middle Aged | 100 | 0.0 |
Research Support, Non-U.S. Gov't | 177 | 0.0 |
Task Performance and Analysis | 4 | 12.0 |
Age Factors | 13 | 0.0 |
Drug Therapy, Combination | 2 | 0.0 |
Hepacivirus/*genetics | 2 | 8.0 |
Quality of Life | 2 | 1.0 |
RNA, Viral/analysis | 4 | 1.0 |
Treatment Outcome | 9 | 0.0 |
Comparative Study | 51 | 0.0 |
Japan | 6 | 0.0 |
*Phonetics | 9 | 64.0 |
Disease Progression | 10 | 0.0 |
English Abstract | 50 | 0.0 |
Genotype | 5 | 0.0 |
Liver/pathology | 3 | 1.0 |
Adolescent | 57 | 0.0 |
Aging/*physiology | 2 | 0.0 |
*Alpha Rhythm | 3 | 75.0 |
Evoked Potentials, Visual/*physiology | 7 | 41.0 |
Frontal Lobe/*physiology | 4 | 28.0 |
Occipital Lobe/physiology | 3 | 30.0 |
Photic Stimulation | 4 | 6.0 |
Regression Analysis | 10 | 0.0 |
Chromosome Mapping | 7 | 0.0 |
*Chromosomes, Human, Pair 1 | 2 | 0.0 |
Genetic Markers | 2 | 0.0 |
In Situ Hybridization, Fluorescence | 7 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 15 | 0.0 |
Gene Library | 2 | 0.0 |
Hematopoietic Stem Cells/physiology | 2 | 4.0 |
Mice | 37 | 0.0 |
Recombinant Proteins/chemistry/metabolism | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 59 | 0.0 |
Transcription, Genetic | 3 | 0.0 |
Transfection | 5 | 0.0 |
Tumor Cells, Cultured | 11 | 0.0 |
Antiviral Agents/*therapeutic use | 3 | 2.0 |
Follow-Up Studies | 9 | 0.0 |
Hepacivirus/isolation & purification | 2 | 12.0 |
Hepatitis C, Chronic/*drug therapy/pathology | 2 | 100.0 |
Liver Function Tests | 2 | 1.0 |
Statistics, Nonparametric | 7 | 0.0 |
Viral Load | 2 | 0.0 |
France | 2 | 0.0 |
Liver/*pathology | 2 | 3.0 |
Longitudinal Studies | 5 | 0.0 |
Nonlinear Dynamics | 2 | 8.0 |
Cohort Studies | 4 | 0.0 |
Interferons/therapeutic use | 2 | 6.0 |
Laterality/*physiology | 6 | 20.0 |
Motor Cortex/*physiology | 6 | 31.0 |
Movement/*physiology | 5 | 13.0 |
Psychomotor Performance/physiology | 3 | 6.0 |
Alanine Transaminase/blood | 2 | 1.0 |
Retrospective Studies | 12 | 0.0 |
Auditory Threshold/physiology | 2 | 10.0 |
Cochlea/*physiology | 2 | 4.0 |
Biological Availability | 3 | 1.0 |
Cattle | 7 | 0.0 |
Chemical Fractionation | 3 | 4.0 |
Chromatography, Affinity | 6 | 0.0 |
Electrophoresis, Agar Gel | 3 | 0.0 |
Filtration | 3 | 6.0 |
Hydrogen-Ion Concentration | 4 | 0.0 |
Molecular Weight | 14 | 0.0 |
Solubility | 4 | 0.0 |
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 0.0 |
Emotions/*physiology | 7 | 50.0 |
*Theta Rhythm | 2 | 40.0 |
Cross-Over Studies | 3 | 0.0 |
Spectrophotometry | 2 | 1.0 |
Amino Acid Sequence | 17 | 0.0 |
Drug Stability | 2 | 0.0 |
Molecular Sequence Data | 24 | 0.0 |
Sequence Deletion | 3 | 0.0 |
Attention/*physiology | 7 | 16.0 |
Electroencephalography | 26 | 10.0 |
Electrooculography | 9 | 21.0 |
Eye Movements/physiology | 3 | 25.0 |
Neuropsychological Tests | 4 | 1.0 |
Pattern Recognition, Visual/*physiology | 4 | 18.0 |
Psychomotor Performance/*physiology | 8 | 19.0 |
Reaction Time/physiology | 17 | 17.0 |
Brain/metabolism | 3 | 0.0 |
Cell Membrane/metabolism | 3 | 0.0 |
*Fish Proteins | 2 | 20.0 |
Glycosylphosphatidylinositols/*metabolism | 2 | 3.0 |
Immunohistochemistry | 6 | 0.0 |
Protein Structure, Tertiary/physiology | 2 | 1.0 |
Rats | 17 | 0.0 |
Mice, Inbred C57BL | 7 | 0.0 |
*Mice, Transgenic | 2 | 4.0 |
Models, Genetic | 2 | 0.0 |
Polymerase Chain Reaction | 6 | 0.0 |
Child | 36 | 0.0 |
Risk Factors | 10 | 0.0 |
Blood Pressure/*physiology | 2 | 2.0 |
Reference Values | 14 | 0.0 |
Reproducibility of Results | 8 | 0.0 |
Blotting, Western | 9 | 0.0 |
Progesterone/*biosynthesis | 2 | 9.0 |
Radioimmunoassay | 2 | 0.0 |
Dose-Response Relationship, Drug | 11 | 0.0 |
Hepatitis C, Chronic/complications/*drug therapy | 2 | 28.0 |
Incidence | 4 | 0.0 |
Japan/epidemiology | 5 | 1.0 |
Multivariate Analysis | 6 | 0.0 |
Axons/*metabolism | 2 | 8.0 |
Binding Sites | 8 | 0.0 |
Cell Adhesion Molecules, Neuronal/chemistry/genetics/*metabolism | 2 | 66.0 |
Cell Fractionation | 4 | 1.0 |
Cells, Cultured | 22 | 0.0 |
Chimeric Proteins/genetics/metabolism | 2 | 2.0 |
In Vitro | 9 | 0.0 |
Precipitin Tests | 2 | 0.0 |
Rats, Wistar | 3 | 0.0 |
Signal Transduction | 2 | 0.0 |
Cytotoxicity Tests, Immunologic | 2 | 0.0 |
Mice, Inbred BALB C | 10 | 0.0 |
Survival Rate | 3 | 0.0 |
Child, Preschool | 7 | 0.0 |
Signal Processing, Computer-Assisted | 6 | 12.0 |
Electrodes | 5 | 11.0 |
Evoked Potentials/*physiology | 5 | 26.0 |
Laterality/physiology | 10 | 19.0 |
Visual Perception/*physiology | 6 | 23.0 |
*Cues | 2 | 18.0 |
Logistic Models | 3 | 0.0 |
*Speech Perception | 12 | 75.0 |
Biological Markers/blood | 2 | 0.0 |
Predictive Value of Tests | 6 | 0.0 |
ROC Curve | 2 | 1.0 |
Sensitivity and Specificity | 14 | 0.0 |
Severity of Illness Index | 3 | 0.0 |
*Language | 5 | 31.0 |
Phonetics | 11 | 50.0 |
*Speech Acoustics | 6 | 75.0 |
Speech Discrimination Tests | 5 | 83.0 |
Speech Perception/physiology | 2 | 25.0 |
Biopsy | 3 | 0.0 |
Body Mass Index | 2 | 0.0 |
Chronic Disease | 7 | 0.0 |
Cell Adhesion | 2 | 0.0 |
Materials Testing | 2 | 2.0 |
Microscopy, Electron, Scanning | 2 | 0.0 |
Analysis of Variance | 14 | 0.0 |
Questionnaires | 3 | 0.0 |
*Brain Mapping | 6 | 12.0 |
Apolipoprotein A-I/blood | 2 | 1.0 |
Bilirubin/blood | 2 | 2.0 |
Biological Markers/*blood | 2 | 1.0 |
Haptoglobins/analysis | 2 | 6.0 |
Hepatitis C, Chronic/*complications/pathology | 2 | 66.0 |
Prospective Studies | 6 | 0.0 |
alpha-Macroglobulins/analysis | 2 | 5.0 |
gamma-Glutamyltransferase/blood | 2 | 4.0 |
Electroencephalography/*methods | 8 | 40.0 |
Gene Expression | 4 | 0.0 |
Korea | 2 | 0.0 |
Germany | 2 | 0.0 |
*Psychiatric Status Rating Scales | 4 | 50.0 |
Alpha Rhythm | 5 | 33.0 |
*Electroencephalography | 37 | 34.0 |
Electromyography | 7 | 3.0 |
Membrane Potentials | 2 | 0.0 |
Movement | 2 | 3.0 |
Brain/*physiology | 10 | 8.0 |
Chickens | 7 | 0.0 |
Chorionic Gonadotropin/pharmacology | 2 | 1.0 |
Follicle Stimulating Hormone/*pharmacology | 2 | 6.0 |
Microscopy, Electron | 4 | 0.0 |
Recombinant Proteins | 2 | 0.0 |
Thymidine/metabolism | 3 | 0.0 |
Tritium | 2 | 0.0 |
Frontal Lobe/*physiopathology | 3 | 50.0 |
Fourier Analysis | 8 | 14.0 |
Karyotyping | 2 | 0.0 |
Restriction Mapping | 4 | 0.0 |
Brain Mapping | 7 | 5.0 |
Cerebral Cortex/physiopathology | 5 | 20.0 |
Event-Related Potentials, P300/*physiology | 2 | 22.0 |
Pain/*physiopathology | 2 | 6.0 |
Photic Stimulation/methods | 5 | 20.0 |
Recurrence | 5 | 0.0 |
Brain/*physiopathology | 5 | 11.0 |
Diagnosis, Differential | 4 | 0.0 |
Case-Control Studies | 7 | 0.0 |
Psychiatric Status Rating Scales | 6 | 2.0 |
Enzyme-Linked Immunosorbent Assay | 10 | 0.0 |
Recombinant Proteins/immunology | 3 | 0.0 |
Brain/*drug effects | 2 | 12.0 |
Structure-Activity Relationship | 5 | 0.0 |
Speech/*physiology | 2 | 16.0 |
Speech Production Measurement | 5 | 41.0 |
Aged, 80 and over | 9 | 0.0 |
Chi-Square Distribution | 2 | 0.0 |
Probability | 2 | 0.0 |
Biomechanics | 3 | 2.0 |
Evoked Potentials/physiology | 5 | 17.0 |
Models, Biological | 4 | 0.0 |
Muscle, Skeletal/physiology | 2 | 5.0 |
Time Factors | 19 | 0.0 |
Reflex/physiology | 2 | 11.0 |
*Chromosome Mapping | 2 | 0.0 |
Mice, Inbred C3H | 2 | 0.0 |
Base Sequence | 11 | 0.0 |
Exons | 3 | 0.0 |
Introns | 2 | 0.0 |
Regulatory Sequences, Nucleic Acid | 2 | 0.0 |
Africa | 2 | 2.0 |
*Genome, Viral | 2 | 2.0 |
Phylogeny | 2 | 0.0 |
Models, Molecular | 3 | 0.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Neuroblastoma | 2 | 1.0 |
Protein Conformation | 5 | 0.0 |
Blood Donors | 2 | 0.0 |
Interferons/*therapeutic use | 4 | 18.0 |
Prognosis | 6 | 0.0 |
Electroencephalography/*drug effects | 8 | 38.0 |
Sequence Alignment | 3 | 0.0 |
Sequence Homology, Amino Acid | 5 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 7 | 0.0 |
Immunoblotting | 2 | 0.0 |
Infant | 12 | 0.0 |
DNA Primers | 5 | 0.0 |
Gene Expression Regulation, Enzymologic/*genetics | 2 | 3.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Huntington Disease/*diagnosis/*physiopathology | 2 | 100.0 |
Volition/physiology | 2 | 66.0 |
Cell Adhesion Molecules, Neuronal/genetics/*metabolism | 2 | 20.0 |
Chick Embryo | 2 | 0.0 |
Mice, Knockout | 2 | 0.0 |
Evoked Potentials, Somatosensory/*physiology | 6 | 22.0 |
Median Nerve/physiology | 4 | 23.0 |
Sound Spectrography | 4 | 36.0 |
Speech Acoustics | 4 | 66.0 |
Algorithms | 2 | 0.0 |
Mental Recall/*physiology | 2 | 15.0 |
Cerebral Cortex/physiology | 8 | 42.0 |
Cognition/physiology | 2 | 6.0 |
Magnetic Resonance Imaging | 3 | 0.0 |
Evoked Potentials | 8 | 15.0 |
Autoimmune Diseases/immunology | 2 | 2.0 |
Celiac Disease/*immunology | 2 | 10.0 |
Cross Reactions | 3 | 0.0 |
Epitopes/*analysis | 2 | 1.0 |
Peptide Fragments/immunology | 3 | 1.0 |
Luteinizing Hormone/pharmacology | 2 | 6.0 |
*Caveolins | 2 | 5.0 |
Cloning, Molecular | 7 | 0.0 |
Arousal/*physiology | 7 | 24.0 |
Attention/physiology | 4 | 13.0 |
Theta Rhythm | 5 | 38.0 |
Thermodynamics | 3 | 0.0 |
Chromatography, High Pressure Liquid | 3 | 0.0 |
Odds Ratio | 2 | 0.0 |
Sex Factors | 7 | 0.0 |
Auditory Threshold | 2 | 5.0 |
Electrocardiography | 2 | 0.0 |
*Hypnosis | 3 | 75.0 |
*Evoked Potentials, Auditory | 2 | 6.0 |
Swine | 2 | 0.0 |
*Event-Related Potentials, P300 | 2 | 100.0 |
*Anesthesia, General | 2 | 9.0 |
Blood Pressure/drug effects | 2 | 0.0 |
Delta Rhythm | 4 | 33.0 |
Heart Rate/drug effects | 2 | 0.0 |
Sleep/*physiology | 4 | 7.0 |
Wakefulness/*physiology | 5 | 31.0 |
Cognition/*physiology | 5 | 7.0 |
Memory/*physiology | 2 | 3.0 |
Cerebral Cortex/*physiology | 5 | 12.0 |
Models, Theoretical | 2 | 1.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
Protein Binding | 5 | 0.0 |
Psychoacoustics | 3 | 20.0 |
Species Specificity | 3 | 0.0 |
Equipment Design | 2 | 1.0 |
Brain Mapping/*methods | 3 | 12.0 |
Fingers/physiology | 2 | 22.0 |
Electric Stimulation | 4 | 1.0 |
*Evoked Potentials, Visual | 4 | 14.0 |
Median Nerve/*physiopathology | 3 | 30.0 |
Dominance, Cerebral/physiology | 3 | 11.0 |
Event-Related Potentials, P300/physiology | 2 | 66.0 |
Evoked Potentials, Auditory/*physiology | 4 | 11.0 |
Reaction Time/*physiology | 4 | 22.0 |
Electrophysiology | 3 | 0.0 |
Nerve Regeneration/*physiology | 2 | 7.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
Afferent Pathways/physiology | 2 | 10.0 |
Frontal Lobe/physiology | 3 | 37.0 |
Somatosensory Cortex/*physiology | 5 | 26.0 |
Cell Division | 2 | 0.0 |
Antibodies, Monoclonal/*immunology | 3 | 0.0 |
Recombinant Proteins/pharmacology | 2 | 0.0 |
Beta Rhythm | 5 | 62.0 |
Cognition | 2 | 3.0 |
Cell Line, Tumor | 3 | 0.0 |
Inbreeding | 2 | 8.0 |
Acoustic Stimulation | 6 | 6.0 |
Pattern Recognition, Visual/physiology | 2 | 15.0 |
Contingent Negative Variation/*physiology | 5 | 71.0 |
Schizophrenic Psychology | 2 | 5.0 |
Antibodies, Monoclonal | 2 | 0.0 |
Cell Membrane/*metabolism | 2 | 0.0 |
Alanine Transaminase/metabolism | 2 | 10.0 |
Binding, Competitive | 2 | 0.0 |
Temperature | 3 | 0.0 |
Enzyme-Linked Immunosorbent Assay/methods | 2 | 0.0 |
Infant, Newborn | 9 | 0.0 |
Sex Characteristics | 3 | 0.0 |
Rabbits | 3 | 0.0 |
Trypsin | 4 | 2.0 |
Exercise/*physiology | 3 | 0.0 |
Flow Cytometry | 2 | 0.0 |
Mice, Transgenic | 2 | 0.0 |
Rats, Inbred Lew | 3 | 1.0 |
*Anesthesia | 2 | 13.0 |
Electroencephalography/drug effects | 2 | 8.0 |
Tomography, X-Ray Computed | 2 | 0.0 |
Laterality | 4 | 7.0 |
Transcription Factors/*metabolism | 2 | 0.0 |
Sleep Stages/physiology | 2 | 11.0 |
Brain/physiology | 3 | 4.0 |
Socioeconomic Factors | 4 | 2.0 |
Electric Stimulation/methods | 2 | 7.0 |
Double-Blind Method | 4 | 0.0 |
*Reading | 2 | 20.0 |
*Infant Food | 3 | 8.0 |
Cell Line | 5 | 0.0 |
Kinetics | 6 | 0.0 |
Antigens, Protozoan/*analysis | 2 | 40.0 |
B-Lymphocytes/immunology | 2 | 0.0 |
Mice, Inbred CBA | 3 | 0.0 |
T-Lymphocytes/immunology | 3 | 0.0 |
Toxoplasma/*immunology | 3 | 13.0 |
Blotting, Northern | 2 | 0.0 |
Brain/*metabolism | 2 | 0.0 |
Protein Structure, Secondary | 2 | 0.0 |
DNA/biosynthesis | 2 | 0.0 |
Motor Activity/*physiology | 2 | 7.0 |
Astragalus membranaceus | 5 | 83.0 |
Cytotoxicity, Immunologic/drug effects | 3 | 2.0 |
Drugs, Chinese Herbal/*pharmacology | 4 | 8.0 |
Interleukin-2/pharmacology | 3 | 0.0 |
Chagas Disease/*immunology | 2 | 11.0 |
Glycoconjugates/chemistry/immunology | 2 | 66.0 |
Oligosaccharides/chemistry/immunology | 2 | 33.0 |
Trypanosoma cruzi/*immunology | 2 | 9.0 |
Models, Neurological | 3 | 2.0 |
Linear Models | 3 | 0.0 |
Phenotype | 4 | 0.0 |
Body Temperature | 2 | 2.0 |
Factor Analysis, Statistical | 2 | 5.0 |
Centrifugation, Density Gradient | 3 | 0.0 |
Brain/physiopathology | 2 | 3.0 |
Brain Mapping/instrumentation | 2 | 40.0 |
Signal Processing, Computer-Assisted/*instrumentation | 2 | 16.0 |
Evoked Potentials, Auditory/physiology | 3 | 33.0 |
Clone Cells | 2 | 0.0 |
Dominance, Cerebral/*physiology | 4 | 30.0 |
*Evoked Potentials, Somatosensory | 5 | 17.0 |
Signal Processing, Computer-Assisted/instrumentation | 2 | 33.0 |
Speech Perception/*physiology | 5 | 50.0 |
Killer Cells, Lymphokine-Activated/*immunology | 3 | 4.0 |
Mice, Inbred DBA | 2 | 0.0 |
Learning/*physiology | 2 | 10.0 |
Dyslexia/*physiopathology | 2 | 100.0 |
Centrifugation | 2 | 2.0 |
Aging/physiology | 2 | 1.0 |
Amino Acids/analysis | 4 | 1.0 |
Cell Division/drug effects | 2 | 0.0 |
Cytosol/immunology | 2 | 28.0 |
Leukemia, Myelocytic, Acute/immunology | 2 | 15.0 |
Lymphocyte Activation | 4 | 0.0 |
Lymphocytes/*drug effects/immunology | 2 | 8.0 |
Dose-Response Relationship, Immunologic | 3 | 0.0 |
T-Lymphocytes/*immunology | 2 | 0.0 |
Chromatography, Thin Layer | 2 | 1.0 |
Antibody Specificity | 2 | 0.0 |
Hybridomas/immunology | 2 | 1.0 |
Heat | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Reading | 2 | 16.0 |
Learning Disorders/*physiopathology | 2 | 66.0 |
*Attention | 2 | 14.0 |
Agglutination Tests | 2 | 4.0 |
Epitopes | 2 | 0.0 |
Fluorescent Antibody Technique | 3 | 0.0 |
Child Development/*physiology | 2 | 16.0 |
Placenta/*enzymology | 2 | 2.0 |
Pregnancy | 7 | 0.0 |
Tumor Cells, Cultured/drug effects | 2 | 0.0 |
Nucleic Acid Hybridization | 2 | 0.0 |
*Contingent Negative Variation | 2 | 66.0 |
*Electrophysiology | 2 | 25.0 |
Interleukin-2/*pharmacology | 2 | 0.0 |
*Lymphocyte Activation | 2 | 0.0 |
*Vibration | 2 | 14.0 |
Reaction Time | 4 | 3.0 |
Lymphocyte Activation/*drug effects | 2 | 0.0 |
Anthropometry | 2 | 0.0 |
Child Language | 2 | 100.0 |
*Speech | 4 | 50.0 |
Subcellular Fractions/analysis | 2 | 28.0 |
Dietary Fats/*metabolism | 2 | 8.0 |
Wakefulness | 2 | 12.0 |
Protein Folding | 2 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Rosette Formation | 2 | 0.0 |
Chromatography, Gel | 4 | 0.0 |
Dominance, Cerebral | 2 | 22.0 |
*Cloning, Molecular | 2 | 0.0 |
DNA, Recombinant | 2 | 1.0 |
Genes | 2 | 0.0 |
Insulin/*genetics | 2 | 3.0 |
Methylation | 2 | 0.0 |
Mice/*genetics | 2 | 0.0 |
Microinjections | 2 | 0.0 |
Plasmids | 2 | 0.0 |
Bile Acids and Salts/*metabolism | 2 | 5.0 |
*Infant, Low Birth Weight | 3 | 13.0 |
Intestinal Absorption | 2 | 1.0 |
*Plants, Medicinal | 2 | 2.0 |
Peptide Fragments/analysis | 2 | 0.0 |
Infant, Premature | 2 | 1.0 |
Pattern Recognition, Visual | 2 | 25.0 |
Histones/*analysis | 2 | 50.0 |
Spermatozoa/*analysis | 2 | 33.0 |
Infant Nutrition | 2 | 9.0 |
Blood Proteins | 2 | 7.0 |
Body Weight | 2 | 0.0 |
